Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Healthtrust
Medtronic
Fuji
US Army
Federal Trade Commission
Express Scripts
Teva
McKinsey
Daiichi Sankyo

Generated: December 11, 2017

DrugPatentWatch Database Preview

CLONIDINE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for clonidine and what is the scope of clonidine patent protection?

Clonidine
is the generic ingredient in nine branded drugs marketed by Boehringer Ingelheim, Actavis Labs Ut Inc, Aveva, Mayne Pharma, Mylan Technologies, Tris Pharma Inc, Exela Pharma Scs Llc, Fresenius Kabi Usa, Hikma Farmaceutica, Luitpold, Zydus Pharms Usa Inc, Mylan Institutional, Actavis Elizabeth, Anchen Pharms, Lupin Ltd, Concordia Pharms Inc, Alembic Pharms Ltd, Am Therap, Aurolife Pharma Llc, Chartwell Molecules, Duramed Pharms Barr, Frontida Biopharm, Impax Labs, Interpharm, Mylan, Par Pharm, Prinston Inc, Sun Pharm Inds Inc, Teva, Unichem, Warner Chilcott, Watson Labs, and Yung Shin Pharm, and is included in sixty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for clonidine. Nine suppliers are listed for this compound.

Pharmacology for CLONIDINE

Medical Subject Heading (MeSH) Categories for CLONIDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Exela Pharma Scs LlcCLONIDINE HYDROCHLORIDEclonidine hydrochlorideINJECTABLE;INJECTION203167-002Oct 29, 2013APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
TevaCLONIDINE HYDROCHLORIDEclonidine hydrochlorideTABLET;ORAL070747-001Jul 8, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Anchen PharmsCLONIDINE HYDROCHLORIDEclonidine hydrochlorideTABLET, EXTENDED RELEASE;ORAL202983-001Apr 2, 2014DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Impax LabsCLONIDINE HYDROCHLORIDEclonidine hydrochlorideTABLET;ORAL078099-002Aug 27, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Mylan InstitutionalDURACLONclonidine hydrochlorideINJECTABLE;INJECTION020615-002Apr 27, 1999APRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Prinston IncCLONIDINE HYDROCHLORIDEclonidine hydrochlorideTABLET;ORAL077901-002Mar 9, 2007ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Actavis ElizabethCLONIDINE HYDROCHLORIDEclonidine hydrochlorideTABLET;ORAL070976-001Dec 16, 1986ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
MylanCLONIDINE HYDROCHLORIDEclonidine hydrochlorideTABLET;ORAL070317-002Jul 9, 1987ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Tris Pharma IncCLONIDINEclonidineTABLET, EXTENDED RELEASE;ORAL022500-001Dec 3, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Par PharmCLONIDINE HYDROCHLORIDEclonidine hydrochlorideTABLET;ORAL070460-001Jul 8, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: clonidine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer IngelheimCATAPRES-TTS-2clonidineFILM, EXTENDED RELEASE;TRANSDERMAL018891-002Oct 10, 1984► Subscribe► Subscribe
Boehringer IngelheimCATAPRES-TTS-3clonidineFILM, EXTENDED RELEASE;TRANSDERMAL018891-003Oct 10, 1984► Subscribe► Subscribe
Boehringer IngelheimCATAPRES-TTS-3clonidineFILM, EXTENDED RELEASE;TRANSDERMAL018891-003Oct 10, 1984► Subscribe► Subscribe
Boehringer IngelheimCATAPRES-TTS-1clonidineFILM, EXTENDED RELEASE;TRANSDERMAL018891-001Oct 10, 1984► Subscribe► Subscribe
Boehringer IngelheimCATAPRES-TTS-2clonidineFILM, EXTENDED RELEASE;TRANSDERMAL018891-002Oct 10, 1984► Subscribe► Subscribe
Boehringer IngelheimCATAPRES-TTS-3clonidineFILM, EXTENDED RELEASE;TRANSDERMAL018891-003Oct 10, 1984► Subscribe► Subscribe
Boehringer IngelheimCATAPRES-TTS-2clonidineFILM, EXTENDED RELEASE;TRANSDERMAL018891-002Oct 10, 1984► Subscribe► Subscribe
Boehringer IngelheimCATAPRES-TTS-2clonidineFILM, EXTENDED RELEASE;TRANSDERMAL018891-002Oct 10, 1984► Subscribe► Subscribe
Boehringer IngelheimCATAPRES-TTS-1clonidineFILM, EXTENDED RELEASE;TRANSDERMAL018891-001Oct 10, 1984► Subscribe► Subscribe
Boehringer IngelheimCATAPRES-TTS-2clonidineFILM, EXTENDED RELEASE;TRANSDERMAL018891-002Oct 10, 1984► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Teva
Merck
QuintilesIMS
Baxter
Farmers Insurance
Novartis
US Department of Justice
McKesson
Medtronic
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot